A systematic review of depression and mental illness preceding Parkinson's disease

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Acta Neurologica Scandinavica

• Publication date

  2006-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/j.1600-0404.2006.00579.xPMID 16542159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Parkinson's disease].

  2022cited by this paper
• Systematic reviews to support evidence-based medicine: how to review and apply findings of healthcare research

  2004cited by this paper
• Psychiatric comorbidity in a population of Parkinson's disease patients

  2004cited by this paper
• Depression in Parkinson’s Disease: Conceptual Issues and Clinical Challenges

  2004cited by this paper
• Higher incidence of depression preceding the onset of Parkinson's disease: A register study

  2003influential reference
• Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese.

  2003cited by this paper
• Prospective study of phobic anxiety and risk of Parkinson's disease

  2003influential reference
• Major depressive disorder in Parkinson's disease: a register‐based study

  2002cited by this paper
• Increased risk of Parkinson’s disease after depression: A retrospective cohort study

  2002influential reference
• Neuropharmacology of depression in aging and age-related diseases.

  2002cited by this paper
• Risk factors of Parkinson's disease in Indian patients.

  2001influential reference
• Personality traits in young patients with Parkinson's disease

  2001cited by this paper
• Systematic Reviews in Health Care: Frontmatter

  2001cited by this paper
• What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study

  2001cited by this paper
• Personality traits and brain dopaminergic function in Parkinson's disease

  2001cited by this paper
• Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study

  2001influential reference
• Cross-cultural traits for personality of patients with Parkinson's disease in Japan.

  2000cited by this paper
• Anxiety disorders and depressive disorders preceding Parkinson's disease: A case‐control study

  2000influential reference
• Epidemiology of Parkinson's disease.

  1999cited by this paper
• Pathophysiology of Secondary Depressions in the Elderly

  1999cited by this paper
• Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study.

  1999cited by this paper
• Parkinson's disease. First of two parts.

  1998cited by this paper
• The Epidemiology of Neurological Disorders

  1998cited by this paper
• The Epidemiology of Parkinson’s Disease in an Australian Population

  1998influential reference
• Personality, depression, and premorbid lifestyle in twin pairs discordant for Parkinson’s disease

  1998cited by this paper
• A population perspective on diagnostic criteria for Parkinson's disease

  1997cited by this paper
• Method for evaluating research and guideline evidence

  1997cited by this paper
• Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.

  1997cited by this paper
• A controlled investigation of current and premorbid personality: Characteristics of Parkinson's disease patients

  1995cited by this paper
• Trait shyness in the elderly: evidence for an association with Parkinson's disease in family members and biochemical correlates.

  1995cited by this paper
• Systematic Reviews: Checklists for review articles

  1994cited by this paper
• [A case-control study of Parkinson's disease].

  1994cited by this paper
• [A case-control study on risk factors in etiology of Parkinson's disease].

  1994cited by this paper
• Personality and Depression in Parkinson's Disease

  1993cited by this paper
• Risk factors for Parkinson's disease

  1993cited by this paper
• Dopamine‐related personality traits in Parkinson's disease

  1993cited by this paper
• Worldwide occurrence of Parkinson's disease: an updated review.

  1993cited by this paper
• What features improve the accuracy of clinical diagnosis in Parkinson's disease

  1992cited by this paper
• Core assessment program for intracerebral transplantations (CAPIT)

  1992cited by this paper
• "Premorbid" personality of patients with Parkinson's disease.

  1992cited by this paper
• Criteria for diagnosing Parkinson's disease

  1992cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• Is there a premorbid personality typical for Parkinson's disease?

  1991cited by this paper
• The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients.

  1991cited by this paper
• The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients.

  1991cited by this paper
• Research diagnostic criteria for Parkinson's disease.

  1990cited by this paper
• Premorbid personality and idiopathic Parkinson's disease.

  1990cited by this paper
• The premorbid personality of patients with Parkinson's disease: a comparative study with healthy controls and patients with essential tremor.

  1990cited by this paper
• Research diagnostic criteria for Parkinson's disease.

  1990influential reference
• The "serotonin hypothesis" for depression in Parkinson's disease.

  1990cited by this paper
• The premorbid personality of patients with Parkinson’s disease

  1989cited by this paper
• A case‐control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease

  1987influential reference
• Parkinson's disease and depression. A critical re-evaluation.

  1986cited by this paper
• The pre-morbid personality of patients with Parkinson's disease.

  1985cited by this paper
• Premorbid personality of Parkinson patients.

  1983cited by this paper
• Depression, intellectual impairment, and Parkinson disease.

  1982cited by this paper
• Delineation of 13q-deletion by replication banding in retinoblastoma.

  1981cited by this paper
• Depression, intellectual impairment, and Parkinson disease

  1981cited by this paper
• Twin study of Parkinson disease

  1981cited by this paper
• Personality Characteristics of Parkinson's Disease

  1981cited by this paper
• EPIDEMIOLOGIC STUDIES OF PARKINSON'S DISEASE: III. A COMMUNITY-BASED SURVEY

  1972influential reference
• Epidemiologic studies of Parkinson's disease. II. A hospital-based survey.

  1972influential reference
• Parkinsonian patients' scores on Hovey's MMPI scale for CNS disorder.

  1972cited by this paper
• Epidemiologic studies of Parkinson's disease. 3. A community-based survey.

  1972cited by this paper
• The previous personality in Parkinsonism.

  1967cited by this paper
• An Essay on the Shaking Palsy

  1817cited by this paper
• Paralysis agitans and multiple sclerosis and their treatment.

  year unknowncited by this paper

• The structure of personality in Parkinson's disease and the effects of age, years since diagnosis, and impulsivity.

  2026cites this paper
• Prevalencia, características demográficas de la enfermedad de Parkinson y comorbilidades asociadas: un análisis del registro oficial del Ministerio de Salud de Colombia

  2025cites this paper
• Effects of Aerobic Exercise on Depressive Symptoms in People with Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2025cites this paper
• Isolated REM sleep without atonia and isolated REM sleep behaviour disorder: a study of clinical and prognostic differences

  2025cites this paper
• Relationship Between Depression and Neurodegeneration: Risk Factor, Prodrome, Consequence, or Something Else? A Scoping Review

  2025cites this paper
• Cognitive behavioral therapy for anxiety and depression symptoms in people of Parkinson’s disease: a systematic review and meta-analysis

  2025cites this paper
• Impact of Parkinson Medication on Neuropsychiatric and Neurocognitive Symptoms in Patients with Advanced Parkinson Disease Prior to Deep Brain Stimulation

  2024cites this paper
• Parkinson's disease subtypes: Approaches and clinical implications.

  2024cites this paper
• A multicenter double-blind randomized crossover study comparing the impact of dorsal subthalamic nucleus deep brain stimulation versus standard care on apathy in Parkinson’s disease: a study protocol

  2024cites this paper
• β-Asarone inhibitsAutophagy by activating the PI3K/Akt/mTOR Pathway in a Rat Model of Depression in Parkinson's Disease.

  2024cites this paper
• Association between dipeptidyl peptidase-4 inhibitor use and risk of Parkinson's disease among patients with diabetes mellitus: a retrospective cohort study.

  2024cites this paper
• Depressive symptoms in Brazilian Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: A Cross-Sectional study.

  2024cites this paper
• Serotonin as a biomarker of toxin-induced Parkinsonism

  2024cites this paper
• An LSTM based DNN Model for Neurological Disease Prediction Using Voice Characteristics

  2024cites this paper
• Satellite fans’ nostalgia buffers negative emotions and increases well-being and travel intention

  2024cites this paper
• Animal Approaches to Studying Risk Factors for Parkinson’s Disease: A Narrative Review

  2024cites this paper
• Navigating Diagnostic Challenges: A Case Report on Early Parkinson's Disease Identification

  2024cites this paper
• Advancing mental health predictions through sleep posture analysis: a stacking ensemble learning approach

  2024cites this paper
• CBD’s potential impact on Parkinson’s disease: An updated overview

  2024cites this paper
• The clinical diagnosis of Parkinson's disease

  2023cites this paper
• Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders

  2023cites this paper
• Neurobiology of Depression in Parkinson's disease: Insights into Epidemiology, Molecular Mechanisms and Treatment Strategies.

  2023cites this paper
• Dysphonia-based Parkinson's Detection using Deep Learning and Ensemble Techniques

  2023cites this paper
• Unveiling the Mind: A Comprehensive Review of Psychiatric Disorders in Parkinson’s Disease

  2023cites this paper
• Electrophysiological signatures of anxiety in Parkinson’s disease

  2023cites this paper
• Application of Neurotoxin-Induced Animal Models in the Study of Parkinson’s Disease-Related Depression: Profile and Proposal

  2022cites this paper
• Brain microstructural alterations of depression in Parkinson's disease: A systematic review of diffusion tensor imaging studies

  2022cites this paper
• Genetic Variants Associated With Resilience in Human and Animal Studies

  2022cites this paper
• Age-Dependent Neuropsychiatric Symptoms in the NF-κB/c-Rel Knockout Mouse Model of Parkinson’s Disease

  2022cites this paper
• Frequency of Depressive Disorders in Parkinson’s Disease: A Systematic Review and Meta-Analysis

  2022cites this paper
• Cognitive dysfunction and neuropsychiatric aspects of Parkinson's disease.

  2022cites this paper
• Changes in gut microbiota composition with age and correlations with gut inflammation in rats

  2022cites this paper
• Nanoparticles in Drug Delivery: From History to Therapeutic Applications

  2022cites this paper
• The pathobiological basis of depression in Parkinson disease: challenges and outlooks

  2022cites this paper
• Who to Enroll in Parkinson Disease Prevention Trials? The Case for Composite Prodromal Cohorts.

  2022cites this paper
• High-frequency rTMS improves quality of life and depressive symptoms in Parkinson’s disease: A case report

  2022cites this paper
• Frontostriatal circuitry as a target for fMRI-based neurofeedback interventions: A systematic review

  2022cites this paper
• Depression in Parkinson's Disease: A Narrative Review

  2022cites this paper
• Parkinson and depression: review and outlook

  2022cites this paper
• Depression and Parkinson's disease: a Chicken-Egg story

  2022cites this paper
• Exercise for depressive symptoms in Parkinson's disease: a systematic review and meta - analysis of randomized controlled trials.

  2022cites this paper
• Dose–Response Association of Metformin with Parkinson’s Disease Odds in Type 2 Diabetes Mellitus

  2022cites this paper
• Changes in the mesocorticolimbic pathway after low dose reserpine-treatment in Wistar and Spontaneously Hypertensive Rat (SHR): implications for cognitive deficits in a progressive animal model for Parkinson's Disease.

  2021cites this paper
• Depression and Related Factors in Patients with Parkinson’s Disease at High Altitude

  2021cites this paper
• Early- Detection of Parkinson’s Disease by Patient Voice Modulation Analysis through MFCC Feature Extraction Technique

  2021cites this paper
• Incidence of antidepressant use among community dwellers with and without Parkinson’s disease – a nationwide cohort study

  2021cites this paper
• NDT_A_300596 1353..1362

  2021cites this paper
• Abnormally reduced frontal cortex activity during Trail-Making-Test in prodromal parkinson's disease-a fNIRS study.

  2021cites this paper
• Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson’s Disease

  2021cites this paper
• The contribution of cognitive behavioural factors to social anxiety in Parkinson’s disease

  2021cites this paper
• Early-life stress induces prodromal features of Parkinsonian with aging in rats.

  2021cites this paper
• Amine Precursors in Depressive Disorders and the Blood-Brain Barrier

  2021cites this paper
• Diabetes Mellitus is Associated with a Higher Relative Risk for Parkinson’s Disease in Women than in Men

  2021cites this paper
• ResearchOnline@ND ResearchOnline

  2021cites this paper
• Parkinson ' s Disease with Device , Diary , or in Disguise . Dyskinesia reduction , motor state evaluation , and workforce participation among persons with Parkinson ' s disease

  2021cites this paper
• Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study.

  2021cites this paper
• Depression in Parkinson’s disease

  2021cites this paper
• Lewy Body Dementias: A Coin with Two Sides?

  2021cites this paper
• Degenerative Movement Disorders of the Central Nervous System

  2021cites this paper
• Impulse Control Disorders in Parkinson’s Disease: From Bench to Bedside

  2021cites this paper
• Treatment response and age of onset as risk indicators for parkinson disease in patients with major depressive disorder: A nationwide longitudinal study.

  2021cites this paper
• Hybrid Model for Parkinson’s Disease Prediction

  2020cites this paper
• Plasma redox and inflammatory patterns during major depressive episodes: a cross-sectional investigation in elderly patients with mood disorders

  2020cites this paper
• Clinically relevant connectivity features define three subtypes of Parkinson's disease patients

  2020cites this paper
• Lewy Body Degenerations as Neuropsychiatric Disorders.

  2020cites this paper
• Future Perspectives on the Relevance of Auditory Markers in Prodromal Parkinson's Disease

  2020cites this paper
• Sexual Dysfunction: Overview of Neurological Diseases and Depression

  2020cites this paper
• Diagnosis of Parkinson’s Disease using Artificial Neural Network

  2020cites this paper
• Depressive disorders in the elderly and dementia: An update

  2020cites this paper
• Impact of depression on gait variability in Parkinson's disease.

  2020cites this paper
• New hopes for disease modification in Parkinson's Disease.

  2020cites this paper
• Telephone-Based, Clinician-Guided Self-Help Cognitive Behavioral Therapy for Depression in Parkinson's Disease (dPD): The Responder Cases of "Alice" and "Carl," and the Nonresponder Cases of "Ethan" and "Gary"

  2020cites this paper
• What contributes to quality of life in Parkinson’s disease: a re-evaluation

  2020cites this paper
• Non-motor symptom burden in patients with Parkinson’s disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort

  2020cites this paper
• Depression in Parkinson's disease: Perspectives from an Australian cohort.

  2020cites this paper
• Phosphodiesterase 2 inhibitor Hcyb1 reverses corticosterone-induced neurotoxicity and depression-like behavior

  2020cites this paper
• The Role of Neurologist in the Assessment and Treatment of Depression

  2020cites this paper
• Diet pattern and prodromal features of Parkinson disease

  2020cites this paper
• Incidence of Parkinson’s disease, dementia, cerebrovascular disease and stroke in bipolar disorder compared to other psychiatric disorders: An electronic health records network study of 66 million people

  2020cites this paper
• Relationship between neuropsychiatric disorders and cognitive and behavioural change in MND

  2019cites this paper
• Malattia di Parkinson e depressione

  2019cites this paper
• Drug treatment strategies for depression in Parkinson disease

  2019cites this paper
• Depression in neurodegenerative diseases: Common mechanisms and current treatment options.

  2019cites this paper
• Mood Effects After Deep Brain Stimulation for Parkinson's Disease: An Update

  2019cites this paper
• Use of Transcranial Magnetic Stimulation in the Correction of Affective Disorders in Parkinson’s Disease

  2019cites this paper
• Shifting ‘stuckness’ in Parkinson’s disease: a music therapy case study

  2019cites this paper
• Effectiveness of imaging genetics analysis to explain degree of depression in Parkinson’s disease

  2019cites this paper
• An association between bipolar disorder and Parkinson disease

  2019influential citation
• The hidden side of Parkinson's disease: Studying pain, anxiety and depression in animal models

  2019cites this paper
• Psychosocial stress enhances susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in C57BL/6N mice.

  2019cites this paper
• Worse Cognitive Performance Predicts Increased Anxiety and Depressive Symptoms in Patients With Parkinson’s Disease: A Bidirectional Analysis

  2019cites this paper
• Maladie de Parkinson et dépression

  2019cites this paper
• Depression as a Risk Factor for Impulse Control Disorders in Parkinson Disease

  2019cites this paper
• Late onset depression: Association with clinical and imaging indicators of prodromal Parkinson’s disease

  2019influential citation
• Depression Screening from Voice Samples of Patients Affected by Parkinson’s Disease

  2019cites this paper
• Are we listening to everything the PARK genes are telling us?

  2019cites this paper
• Ages at Onset of Anxiety and Depressive Disorders in Parkinson's Disease.

  2019cites this paper
• Is Dementia in Parkinson’ Disease Related to Chronic Stress, Anxiety, and Depression?

  2019cites this paper
• Granular Computing (GC) Demonstrates Interactions Between Depression and Symptoms Development in Parkinson's Disease Patients

  2019cites this paper
• Association between depression and the subsequent risk of Parkinson's disease: A meta‐analysis

  2018cites this paper